BSX
Price
$67.96
Change
-$0.15 (-0.22%)
Updated
Apr 17, 6:59 PM EST
6 days until earnings call
TFX
Price
$208.24
Change
-$1.94 (-0.92%)
Updated
Apr 17, 6:59 PM EST
7 days until earnings call
Ad is loading...

BSX vs TFX ᐉ Comparison: Which is Better to Invest?

Header iconBSX vs TFX Comparison
Open Charts BSX vs TFXBanner chart's image
Boston Scientific
Price$67.96
Change-$0.15 (-0.22%)
Volume$2.3M
CapitalizationN/A
Teleflex
Price$208.24
Change-$1.94 (-0.92%)
Volume$40.92K
CapitalizationN/A
View a ticker or compare two or three
BSX vs TFX Comparison Chart

Loading...

BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TFXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BSX vs. TFX commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongSell and TFX is a Hold.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (BSX: $68.12 vs. TFX: $210.10)
Brand notoriety: BSX: Notable vs. TFX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 115% vs. TFX: 68%
Market capitalization -- BSX: $100.1B vs. TFX: $10.49B
BSX [@Medical Specialties] is valued at $100.1B. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 3 TA indicator(s) are bullish while TFX’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 3 bullish, 2 bearish.
  • TFX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than TFX.

Price Growth

BSX (@Medical Specialties) experienced а -0.79% price change this week, while TFX (@Medical Specialties) price change was -6.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.56%. For the same industry, the average monthly price growth was -3.67%, and the average quarterly price growth was +9.98%.

Reported Earning Dates

BSX is expected to report earnings on Jul 24, 2024.

TFX is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (-3.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
A.I.dvisor published
a Summary for TFX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than TFX($10.5B). BSX has higher P/E ratio than TFX: BSX (63.64) vs TFX (29.48). BSX YTD gains are higher at: 17.834 vs. TFX (-15.610). BSX has higher annual earnings (EBITDA): 3.45B vs. TFX (761M). BSX has more cash in the bank: 865M vs. TFX (223M). TFX has less debt than BSX: TFX (1.93B) vs BSX (9.49B). BSX has higher revenues than TFX: BSX (14.2B) vs TFX (2.97B).
BSXTFXBSX / TFX
Capitalization100B10.5B952%
EBITDA3.45B761M453%
Gain YTD17.834-15.610-114%
P/E Ratio63.6429.48216%
Revenue14.2B2.97B477%
Total Cash865M223M388%
Total Debt9.49B1.93B493%
FUNDAMENTALS RATINGS
BSX vs TFX: Fundamental Ratings
BSX
TFX
OUTLOOK RATING
1..100
7058
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
17100
SMR RATING
1..100
7676
PRICE GROWTH RATING
1..100
5342
P/E GROWTH RATING
1..100
8973
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for BSX (81). This means that TFX’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (17) in the Medical Specialties industry is significantly better than the same rating for TFX (100). This means that BSX’s stock grew significantly faster than TFX’s over the last 12 months.

BSX's SMR Rating (76) in the Medical Specialties industry is in the same range as TFX (76). This means that BSX’s stock grew similarly to TFX’s over the last 12 months.

TFX's Price Growth Rating (42) in the Medical Specialties industry is in the same range as BSX (53). This means that TFX’s stock grew similarly to BSX’s over the last 12 months.

TFX's P/E Growth Rating (73) in the Medical Specialties industry is in the same range as BSX (89). This means that TFX’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXTFX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 22 days ago
60%
Bullish Trend 21 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 2 days ago
67%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
65%
View a ticker or compare two or three
Ad is loading...
BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TFXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HDGE21.490.20
+0.94%
AdvisorShares Ranger Equity Bear ETF
UGL83.210.24
+0.29%
ProShares Ultra Gold
EQRR59.25-0.14
-0.24%
ProShares Equities for Rising Rates ETF
VTV154.82-0.61
-0.39%
Vanguard Value ETF
GLTR103.84-0.96
-0.92%
abrdn Physical PrecMtlBsk Shrs ETF

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with SYK. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.01%
SYK - BSX
68%
Closely correlated
-0.43%
RVTY - BSX
52%
Loosely correlated
-1.99%
ISRG - BSX
52%
Loosely correlated
+0.32%
ZBH - BSX
51%
Loosely correlated
-1.56%
ABT - BSX
45%
Loosely correlated
+0.29%
More